A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE)
Authors:
- Pol Camps-RenomPCPol Camps-Renom
- Marina Guasch-JiménezMGMarina Guasch-Jiménez
- Alejandro Martínez-DomeñoAMAlejandro Martínez-Domeño
- Luis Prats-SánchezLPLuis Prats-Sánchez
- Anna Ramos-PachónARAnna Ramos-Pachón
- Juan Álvarez-CienfuegosJÁJuan Álvarez-Cienfuegos
- Yolanda SilvaYSYolanda Silva
- Gerardo Fortea-CaboGFGerardo Fortea-Cabo
- Luis Morales-CabaLMLuis Morales-Caba
- Ana Rodríguez-CampelloARAna Rodríguez-Campello
- Eva Giralt-SteinhauerEGEva Giralt-Steinhauer
- Alan FloresAFAlan Flores
Open Access
- 29 August 2024
- journal article
- research article
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 54 (4) , 1-8
Abstract
Introduction: In patients with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion, optimal blood pressure (BP) management following endovascular treatment (EVT) has not yet been established. The randomized trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE) (clinicaltrials.gov id: NCT04892511) aims to demonstrate whether hemodynamic optimization using different systolic BP targets following EVT according to the degree of final recanalization, is more effective than currently recommended BP management in improving functional outcomes of patients with AIS. Methods: HOPE is an investigator-initiated multicenter clinical trial with randomized allocation, open-label treatment, and blinded endpoint evaluation (PROBE). Patients with an anterior circulation AIS within 24 h of symptom onset, treated with EVT, and showing successful recanalization (mTICI ≥2b) at the end of the procedure, are equally allocated (1:1) to hemodynamic optimization according to the study protocol versus BP management according to current guidelines (≤180/105 mm Hg). The protocol includes two different targets of systolic BP depending on the recanalization status (mTICI = 2b: 140–160 mm Hg; mTICI = 2c/3: 100–140 mm Hg). The protocol is applied within the first 72 h and includes BP lowering as well as vasopressor therapies when needed. The primary outcome is the proportion of favorable outcome (modified Rankin Scale [mRS] 0–2) at 90 days. Secondary outcomes include the shift on the mRS score, neurological deterioration, symptomatic intracerebral hemorrhage, and mortality. Conclusion: The HOPE trial will provide new information on the safety and efficacy of different BP targets following EVT according to the degree of final recanalization in patients with AIS.Keywords
This publication has 16 references indexed in Scilit:
- Blood Pressure after Successful Endovascular Therapy: A Systematic Review and Meta‐Analysis of Randomized Control TrialsAnnals of Neurology, 2024
- Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic StrokeJAMA, 2023
- Blood Pressure Management After Endovascular Therapy for Acute Ischemic StrokeJAMA, 2023
- Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trialThe Lancet, 2022
- Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trialThe Lancet Neurology, 2021
- Blood Pressure Goals and Clinical Outcomes after Successful Endovascular Therapy: A Multicenter StudyAnnals of Neurology, 2020
- 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke AssociationStroke, 2018
- Systolic Blood Pressure Within 24 Hours After Thrombectomy for Acute Ischemic Stroke Correlates With OutcomeJournal of the American Heart Association, 2017
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Lower Intraprocedural Systolic Blood Pressure Predicts Good Outcome in Patients Undergoing Endovascular Therapy for Acute Ischemic StrokeInterventional Neurology, 2015